Drug-resistant parietal epilepsy: polymorphic ictal semiology does not preclude good post-surgical outcome

Stefano Francione1, Alexandra Liava2, Roberto Mai1

  • 1"Claudio Munari" Epilepsy Surgery Centre, Niguarda Ca' Granda Hospital.

Insights

Parietal lobe epilepsy surgery in children and adults shows 75% success, with pediatric patients achieving better outcomes and drug discontinuation. Complete resection of the seizure focus is key for successful surgical treatment.

Area of Science:

  • Neurosurgery
  • Epileptology
  • Clinical Neurology

Background:

  • Pharmacoresistant epilepsy often necessitates surgical intervention.
  • Parietal lobe epilepsy presents unique diagnostic and therapeutic challenges.
  • Understanding the specific features of parietal lobe seizures is crucial for surgical planning.

Purpose of the Study:

  • To analyze the anatomo-electro-clinical features and surgical outcomes of parietal lobe resections.
  • To compare outcomes between pediatric and adult patients undergoing parietal lobe surgery.
  • To identify predictors of successful surgical treatment for pharmacoresistant parietal lobe epilepsy.

Main Methods:

  • Retrospective analysis of 40 consecutive patients with pharmacoresistant seizures undergoing parietal lobe resection.
  • Subgroup analysis of pediatric (n=11) and adult (n=29) populations.
  • Evaluation of clinical outcomes using Engel classification and seizure recurrence rates.
  • Correlation analysis of pre-operative factors, surgical techniques, and post-operative results.

Main Results:

  • Overall, 75% of patients achieved Engel Class I outcome after a mean follow-up of 9.4 years.
  • Pediatric patients exhibited more comorbidities but had significantly better surgical outcomes and higher rates of drug discontinuation.
  • Total resection of the epileptogenic zone and localizing interictal electroencephalography (EEG) were significant predictors of favorable outcomes.
  • Parietal lobe seizures are characterized by diverse auras and secondary generalization, which did not negatively impact surgical results.

Conclusions:

  • Surgical resection confined to the parietal lobe is an effective treatment for pharmacoresistant epilepsy, with high success rates.
  • Pediatric patients with parietal lobe epilepsy benefit significantly from surgery, often achieving better seizure control and medication independence.
  • Complete resection of the epileptogenic zone, guided by EEG, is paramount for optimizing surgical outcomes in parietal lobe epilepsy.